B-ENT

Belgian guidelines for the treatment of acute rhinosinusitis in general practice

1.

Department of Otorhinolaryngology, Ghent University Hospital, Ghent

2.

Department of Otorhinolaryngology, Cliniques Universitaires Mont-Godinne, Yvoir, Belgium

3.

ENT-HNS Department, CHR Citadelle, Liège Belgium

4.

Department of Otorhinolaryngology, Head and Neck surgery, University hospitals Leuven, Leuven, Belgium

5.

Service d’Oto-Rhino-Laryngologie et d’Audiophonologie, Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart Tilman, Liège

6.

Department of Otorhinolaryngology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

7.

ENT Department, ZNA Middelheim, Lindendreef 1, 2020 Antwerpen

B-ENT 2007; 3: 175-177
Read: 522 Downloads: 415 Published: 21 February 2020

Belgian guidelines for the treatment of acute rhinosinusitis in general practice. Management and treatment guidelines for rhinosinusitis and nasal polyps have been published by the European Academy for Allergy and Clinical Immunology (EAACI) task force in 2005,1 and have recently been updated.2 These guidelines are evidence-based and internationally recognized, and form the basis for the here presented “Belgian Guidelines for the treatment of ARS in general practice”, developed by the sinusitis committee. This document is intended to establish evidence-based management procedures for ARS, one of the most frequent upper airway diseases, mostly treated by the general practitioner. It is recommended to treat ARS with topical glucocorticosteroids 200 mcg BID. Antibiotics are recommended for the treatment of severe ARS, if need be, together with topical glucocorticosteroids BID.

Files
EISSN 2684-4907